v3.25.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
12 Months Ended
Feb. 19, 2025
Aug. 14, 2024
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Apr. 08, 2022
May 10, 2021
Subsidiary, Sale of Stock [Line Items]              
Income tax net     $ 0 $ 0      
Stock issued new, value     $ 6,270,136        
August 2024 Sale [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock issued new, shares   265,868          
Share price   $ 5.25          
Purchase price per share   $ 5.79          
Stock issued new, value   $ 1,200,000          
February 2025 Sale [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock issued new, shares 1,272,500            
Share price $ 4.00            
Stock issued new, value $ 5,100,000            
Common stock par value $ 0.01            
Plan 2022 [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares authorized for issuance under the plan           933,333  
Stock options outstanding     876,091        
Shares available for future grants     57,242        
Plan 2021 [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares authorized for issuance under the plan             333,333
Stock options outstanding     264,495        
Plan 2011 [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock options outstanding     482,990        
Plan 2006 [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock options outstanding     0        
Equity Option [Member]              
Subsidiary, Sale of Stock [Line Items]              
Unrecognized compensation costs related to options vesting     $ 1,409,980        
Stock options outstanding     1,623,576 1,357,735 1,127,140    
Aggregate intrinsic value outstanding     $ 833,438        
Aggregate intrinsic value exercisable     $ 787,363        
Stock Options [Member]              
Subsidiary, Sale of Stock [Line Items]              
Options granted     520,000 285,527